With the exception of aldosterone, little is known about the hormonal regulation of distal nephron acidification. These experiments investigated the effects of prostaglandin E2, indomethacin, lysyl-bradykinin, 8-bromo-cyclic AMP, and forskolin on proton secretion in the major acidifying segment of the distal nephron, the medullary collecting duct from inner stripe of outer medulla.
Introduction
The distal nephron is important as the final determinant of urinary acidification (1) (2) (3) (4) . Acidification ofthe urine occurs in several distinct distal nephron segments including the distal convoluted tubule, cortical collecting tubule, medullary and papillary collecting ducts (5) (6) (7) (8) (9) (10) . The capacity for collecting duct proton secretion (or bicarbonate reabsorption) shows segmental differences. The rat distal convoluted tubule and the rabbit cortical collecting tubule possess a low capacity for acidification (5) (6) (7) (8) .
In contrast, the medullary collecting tubule from the rabbit and rat secretes protons at a higher rate (7) (8) (9) 11) . Several transport characteristics ofthe medullary collecting tubule make it an ideal segment to study the regulation of distal nephron acidification. These include no evidence for spontaneous net sodium or potassium transport (12); no evidence for bicarbonate secretion (8, 13) ; independence of proton secretion from sodium transport or from the presence of sodium in luminal and peritubular fluids (7, 14) . With respect to active transport, the medullary collecting tubule thus appears to be involved exclusively in proton secretion.
Two categories of controlling influences may be important in considering the regulation of acidification by the medullary collecting duct. The first group offactors that may regulate acidification in this nephron segment is an alteration in pH (both respiratory and metabolic). Previous studies on medullary collecting duct acidification have already examined the effects of both in vivo and in vitro alterations in the acid-base status and environment ofthe rabbit and rabbit tubule (8, 13) . The second broad category ofpotential regulatory factors includes a number of hormones or hormone messengers that are known to affect certain transport processes in the distal nephron. The most studied and best known of these hormonal regulatory factors is aldosterone, which has been shown to influence acidification in both cortical and medullary collecting tubules (14) (15) (16) (17) . Much less is known about the effects of other hormones or mediators ofhormone action on distal nephron proton secretion. This study examines the effects of the prostaglandin E2 (PGE2)1 and lysylbradykinin on medullary collecting duct acidification. In addition, the effects of cyclic AMP, the common second messenger, were examined since a number ofhormonal actions on epithelial cells involve alteration ofintracellular levels ofcyclic nucleotides.
Methods

Microperfusion-general experimental features
The technique ofin vitro microperfusion was as previously described by Burg (18) . Briefly, female New Zealand White rabbits weighing 1.5-2.5 kg were maintained on standard laboratory chow and tap water ad lib. Animals were decapitated and the left kidney rapidly removed, decapsulated, and sliced into 1-mm coronal slices. Slices were placed in oxygenated bathing solution at 40C, pH 7.40. One perfusate and two bathing solutions were utilized in the protocols. The perfusate was an artificial plasma ultrafiltrate containing (in mM) NaCI, 105; KC1, 5; NaHCO3, 25; Na acetate, 10; NaHPO4, 2.3; CaCl2, 1.2; MgSO4, 1; glucose, 8.3; and alanine, 5. Bathing solutions in all experiments except those with lysyl-bradykinin contained 5% vol/vol fetal calfserum. In protocols utilizing lysyl-bradykinin in the bathing solution, the bath was identical in composition except for 2.4 mM CaCl2 and 6 g/100 ml defatted bovine serum albumin (CRG-7, Armour Pharmaceutical Co., Kankakee, IL). Albumin was added instead offetal calfserum to lessen lysyl-bradykinin metabolism. In protocols utilizing indomethacin, solutions were identical to those used in the lysyl-bradykinin experiments with 2.4 mM CaCl2 and 6 g/100 ml defatted bovine serum albumin, but in addition 5% vol/ vol fetal calf serum was present. Bathing solutions and perfusate were gassed at 37-C with 95% 02/5% CO2 to pH 7.35-7.40 and drawn anaerobically into syringes for use. The dissection medium was made hypertonic (450 mosM) by addition of NaCl to facilitate tubule harvest. Segments ofmedullary collecting duct (MCD) from inner stripe ofouter renal medulla (OMCT) were anatomically identified as previously described by Stone et al. (9) . Tubules were transferred to a thermostatically controlled lucite perfusion chamber and perfused between concentric glass pipettes at 370C. The tubular ends of each glass holding pipette contained elastomeric silicone resin (Sylgard 184, Dow Corning Corp., Midland, MI) to provide both an electrical and water seal. Perfusion rate was hydrostatically controlled to a rate of 1-3 nl/min. Bathing solutions were constantly exchanged at 0.6 ml * min-' with an infusion pump (Sage Instruments, Div. Orion Research, Inc., Cambridge, MA). A perfusion pipette, centered in one of the holding pipettes, was advanced 50-100 um into the tubule lumen. This pipette also served as an intraluminal electrode because it was connected via a Ringer's agarose bridge to a calomel half-cell. The circuit was completed by a similar agarose bridge placed in the perfusion chamber and connected to a second calomel halfcell. Transepithelial voltage (VT) thus was monitored continuously throughout the experiment. VT was measured with a battery-operated electrometer (model 602, Keithley Instruments, Inc., Cleveland, OH) and recorded on a strip-chart recorder (Rikadenki model B26 1, Soltec Corp., Sun Valley, CA). Timed samples of tubular fluid were collected in a constant volume pipette (CVP) under water-equilibrated mineral oil. This pipette was calibrated for each experiment as previously described by Schuster et al. ( 19) .
Tubules were equilibrated for 60 min at 370C before experimentation.
Net volume absorption was determined by using exhaustively dialyzed methoxy[3Hfinulin (New England Nuclear, Boston, MA) as a volume marker by the method of Schafer et al. (20) . Net volume flux (Jv) was calibrated from differences in [3H] inulin activity between perfused and collected fluid as previously described (21) . Net total CO2 flux (JHCO3) was determined by microcalorimetry and calculated according to the following equation (22) Since indomethacin produced an increase in proton secretion and because desoxycorticosterone acetate (DOCA) pretreatment has been shown to decrease PGE2 production by rabbit cortical collecting tubules in vitro (23) , indomethacin in tubules harvested from surgically adrenalectomized rabbits was tested. Our laboratory has shown that proton secretion rates are reduced in
OMjCT from adrenalectomized rabbits (14) , an observation compatible with but obviously not proof of elevated PGE2 production rates. If indomethacin produced a significantly greater increase in proton secretion by tubules from adrenalectomized rabbits, we would have evidence for enhanced PGE2 production by these tubules. However, no studies to date have been performed to measure PGE2 production rates by medullary collecting ducts in vitro, from adrenalectomized rabbits. As shown in Table I and Fig. 2 Effects oflysyl-bradykinin on acidification. After a demonstrated prostaglandin effect on MCD acidification was observed, and appreciating the fact that lysyl-bradykinin is a potent stimulator of PGE2 production in cultured rabbit papillary collecting duct cells (24) , the effect oflysyl-bradykinin on proton secretion was examined.
As shown in Table I and Fig. 3 , there was no significant change in proton secretion from control values, 8 (----) Surgically adrenalectomized rabbits (ADX). (25) . As shown in Table I Discussion tubule and the various regions of the collecting duct constitute the specific nephron segments involved. Coincident with our appreciation of the importance of distal nephron transport events, is the impressive documentation that several systemic and intrarenal hormones modulate Na, K, Cl, and water transport in the distal nephron (19, 28, (31) (32) (33) (34) (35) (36) (37) (38) (39) . The systemic hormones aldosterone and vasopressin thus regulate Na, K, Cl, and water movement across portions of the distal nephron (28, (31) (32) (33) (34) . Similarly, the intrarenal hormones prostaglandin E2 and bradykinin have been shown to modulate salt and water transport in the cortical collecting duct (19, (35) (36) (37) (38) (39) .
Although the distal nephron is the final determinant of net acid excretion, information concerning the hormonal regulation of acidification in this region of the kidney is limited. The systemic hormone aldosterone has been shown to influence net acidification in both cortical and medullary collecting tubules (7-9, 14, 15, 17) . Also, earlier studies in epithelia analogous to the collecting duct (toad urinary bladder) have demonstrated an effect ofvasopressin on proton movement (40>, although a physiologic role for vasopressin in acidification is not apparent. There has been no systematic examination of the effects of intrarenal hormones, which are known to be produced and to effect transport in the distal nephron, on acidification.
Our aim was to define whether or not the intrarenal hormones, PGE2 and lysyl-bradykinin and the important mediator of hormonal action, cyclic AMP, played any role in regulating net proton secretion in the OMiCT. While we have presented evidence for a role of PGE2 and cyclic AMP, we were unable to detect any action of lysyl-bradykinin.
Several aspects of our studies require discussion. These include (a) the magnitude of the observed changes, (b) the possibility of cyclic AMP and prostaglandin E2 interaction, (c) the cellular mechanism of action of the hormonal agents, (d) the lack of effect of lysyl-bradykinin, and (e) the physiologic significance of our findings.
First, the changes observed in net acidification were small but consistent. PGE2 inhibited proton secretion, while indomethacin stimulated proton secretion. We are not concerned with the lack of reversibility ofPGE2 on proton secretion because indomethacin had the expected opposite effect of stimulating proton secretion. The results were also internally consistent with exogenous cyclic AMP stimulating proton secretion and forskolin, a known activator ofadenylate cyclase (26) , also stimulating proton secretion. The distal nephron is important in the regulation ofmany urinary solutes. This is especially true with respect to Na, K, C1, and net acid excretion (1, 9, 10, 12, 14, 27-30). The distal convoluted The changes in net acidification may have been greater if higher doses of the hormones were used. With respect to the concentrations used, however, careful attention was paid to previous studies examining the effects of these same substances on other aspects of collecting duct and medullary tissue transport. Specifically, our use of PGE2 at a concentration of 10-6 M is 10-fold greater than the PGE2 concentration required for maximal inhibition of the antidiuretic hormone (ADH) dependent transepithelial voltage in mouse medullary thick ascending limb tubules (41) . However, it is identical to the concentration used by Stokes and Kokko (38) to inhibit Na transport in cortical collecting tubules. Similarly, forskolin at 10-6 M is the concentration required to produce a maximal increase in transepithelial voltage of mouse medullary thick ascending limb tubules (42).
l0-' M 8-bromo-cyclic AMP is a log lower concentration than that shown by Schuster to stimulate bicarbonate secretion in rabbit cortical collecting tubules (37) . Furthermore, 50 ,gM and 125 gM indomethacin used in bathing solutions containing both 6% bovine serum albumin and 5% vol/vol fetal calf serum are two-and fourfold lower concentrations than those used by Kirschenbaum et al. (23) to alter water transport in cortical collecting tubules. In most species, greater than 90% of indomethacin is bound to the nondiffusible constituents of plasma (43) . With both bovine serum albumin and fetal calf serum present in our indomethacin experiments, the free concentration would probably be much lower. Finally, lo-' M lysyl-bradykinin is the concentration shown previously to increase PGE2 production in cultured canine cortical collecting duct cells (44) .
The second point we wish to address is the possible interaction between PGE2 and cyclic AMP. Interactions between cyclic AMP and PGE2 have been reported in several different tissues. Hassid found cyclic AMP to inhibit prostaglandin biosynthesis in MDCK cells by modulating the activity of two or more ofthe enzymes involved in the prostaglandin biosynthetic process (25) . Moreover, Teitelbaum and Berl have recently confirmed this inhibition of PGE2 production by cyclic AMP in rat inner medullary cells (45, 46) . Thus, it appears that in renal medullary tissue, cyclic AMP may reduce PGE2 formation.
Conversely, regulation of adenylate cyclase by prostaglandins has been demonstrated in the adipocyte where PGE2 activates the inhibitory subunit (Ga) of adenylate cyclase leading to decreased intracellular cyclic AMP levels (47) . However, in other tissues PGE2 may reduce or increase cyclic AMP levels (48) (49) (50) (51) (52) (53) . Most recently, in mouse medullary thick ascending limb of Henle (mTALH), Culpepper investigated the mechanism of PGE2 suppression of ADH-dependent NaCl transport, which is stimulated by cyclic AMP. Using forskolin and cholera toxin, PGE2 appeared to inhibit ADH stimulation of NaCl transport in the mTALH by an action distal to hormone-receptor interactions, yet proximal to the catalytic subunit of adenylate cyclase (42) . Similar to the adipocyte, it appears that PGE2 may suppress the rate of cyclic AMP formation in mouse renal medullary cells by interacting with the (Gi) subunit ofadenylate cyclase enzyme. This is further substantiated by the recent work of Schuster. Using pertussis toxin, Schuster found bradykinin-stimulated PGE2 inhibits the ADH effect on water flow by inhibiting cAMP production at the (Gi) subunit of adenylate cyclase enzyme in rabbit cortical collecting tubules (54) . There is thus evidence for important interactions between cyclic AMP and prostaglandins in several cell lines including renal medullary tissues. Although these specific interactions between cyclic AMP and PGE2 were not explored in our investigation, the fact that PGE2 inhibited and cyclic AMP stimulated proton secretion in the rabbit medullary collecting duct suggests art interaction may be operative. Cyclic AMP may inhibit PGE2 synthesis and PGE2 may inhibit cyclic AMP formation, accounting for the opposite effects on acidification.
Next, we wish to address the possible mechanisms of action of these hormones. At least three possible mechanisms can be construed. PGE2 and cyclic AMP may act by (a) primarily altering the electrogenic apical membrane proton translocating ATPase, (b) primarily altering electroneutral basolateral chloridebicarbonate exchange, or (c) primarily altering transcellular or paracellular chloride movement.
With only VT and JHCO3 data, it is difficult to assign a primary mechanism of action for these substances, since it is likely that a primary effect on one process may have rapid secondary effects on the other processes. These processes may be tightly linked within the cell, and VT and JHCO3 measurements alone cannot allow one to distinguish between primary and secondary effects. Electrophysiologic measurements of basolateral Cl-conductance, apical and basolateral membrane resistances, and intracellular Cl-concentrations are needed to discern the mechanism of action of these hormones.
Although we cannot assign a mechanism of action for these hormones from our data, it would be interesting to speculate that cyclic AMP increases basolateral C1-conductance as seen in several other epithelia (55-58) PGE2 action may be through interactions with the adenylate cyclase system as described above, to decrease basolateral membrane Cl-conductance. These possibilities, however, would have to be proven with electrophysiologic measurements.
We would next like to comment on the absence of a lysylbradykinin effect. Previous studies in renal tissue have revealed enhanced PGE2 production following exposure to lysyl-bradykinin (24, 44, 59 ). In cultured rabbit papillary collecting duct cells and cultured canine cortical collecting tubule cells, bradykinin increased PGE2 formation significantly (24, 44) . Following lysyl-bradykinin exposure in our experiments, no significant effect on net proton secretion in the OMjCT was found.
In previous experiments Schuster et al. (19) formed (not shown) again with no significant effect on proton secretion.
In rat inner medullary cells, Teitelbaum and Berl found only a small increase in PGE2 production (18.5±2.4 to 39.9±4.4 pg ,ug protein-' * h-') following the addition of 10-6 M bradykinin (60). Using a log lower concentration (l0-7 M) in our experiments the increase in prostaglandin production might even be less. With such a small rise in PGE2 production due to lysylbradykinin, one might not expect to see the same effect as with exogenous 10-6 M PGE2. Furthermore, intact tubules and cultured cells may respond differently to known stimulators of prostaglandin biosynthesis. Although 33 MM arachidonic acid produces a 250-fold increase of prostaglandin synthesis in cultured collecting duct cells from rabbits, only a-sevenfold increase occurs in intact cortical collecting tubules from the same species (61) . In microdissected medullary collecting tubules, Schlondorff found that 10-6 M lysyl-bradykinin prevented the fall in PGE2 production they found to occur with time. However, there was variability among tubules (even from the same animal), and in some tubules the fall in PGE2 production with lysyl-bradykinin was greater than in controls (62) . It is therefore possible that stimulation of PGE2 production in OMjCT occurs with lysylbradykinin but the increase is too small to alter acidification significantly.
There are thus at least three possible explanations for the failure to demonstrate a lysyl-bradykinin effect on proton secretion. First, as discussed above, OMjCT perfused in vitro may not increase PGE2 production significantly in response to lysylbradykinin. Secondly, in QMCT perfused in vitro, the process ofdissection and manipulation ofthe tubule for experimentation may stimulate PGE2 production maximally by activating phospholipase (63). Addition of lysyl-bradykinin may not stimulate PGE2 production further in this setting. However, the relatively -small absolute increase in proton secretion in response to indomethacin might argue against this. Finally, lysyl-bradykinin may have two separate effects, one to stimulate PGE2 production, thus inhibiting proton secretion, and another to stimulate proton secretion directly resulting in no net effect on proton secretion.
We would like to comment on the possible physiologic significance of our observations. Hormonal effects on net distal nephron acidification must take into consideration the whole distal nephron, i.e., distal convoluted tubule, connecting segment, cortical, medullary and papillary collecting tubules. While we have shown effects on OMCT acidification, these hormones may have differing effects on other distal segments. With respect to cyclic AMP, this compound has been shown to enhance bicarbonate secretion in the cortical collecting tubule, an effect opposite to that shown in the OMCT. In the turtle bladder and toad bladder, which have the capacity to both secrete and reabsorb bicarbonate, cyclic AMP has been shown to have varied and at times conflicting effects. Cyclic AMP may inhibit proton secretion (64) , stimulate proton secretion (65, 66) , stimulate electrogenic bicarbonate secretion (67), or increase passive bicarbonate permeability (68) . It is apparent, therefore, that any effect cyclic AMP might have on net urinary acidification will depend on which distal nephron segment or cell type it is acting upon. This, ofcourse, will be dependent on the specific regulators of cyclic AMP metabolism and may, in addition to PGE2, include a number of well-known hormones such as aldosterone, catecholamines, and parathyroid hormone (69, 70) .
With respect to PGE2, recent studies are in agreement with our results in the OMICT. Ascer found that PGE2 inhibits turtle bladder proton secretion in a dose-related fashion from IO-' to IO' M (71). Moreover, Kapour used in vivo clearance studies and found increased ammonia production with cyclooxygenase inhibition in both normal and acidotic rats (72) . Prostaglandins thus may inhibit ammonia production and proton secretion. In summary, rabbit OMCT were studied in vitro to examine the influence of the intrarenal hormones PGE2 and lysyl-bradykinin, and the common second messenger cyclic AMP, on proton secretion. These studies demonstrate that (a) PGE2 inhibits and cyclooxygenase inhibition stimulates proton secretion in the rabbit OM1CT, (b) exogenous cyclic AMP and elevation of endogenous cyclic AMP with forskolin stimulate proton secretion in the rabbit OMjCT, and (c) lysyl-bradykinin has no effect on proton secretion in the rabbit OMjCT.
